President Donald Trump signed a $1.2 trillion spending package through 2026.[4][5][6][7] This law ended a partial government shutdown that lasted four days.[4][5][6] The legislation includes major reforms for pharmacy benefit managers (PBMs), which could radically change how they operate.[original content] In addition, Trump has struck deals with pharmaceutical companies such as Eli Lilly and Novo Nordisk to lower the prices of diet pills.[1] Prices for these drugs in the US reach more than $1,000 per month and are reduced for Medicare and Medicaid.[1] The drugs will be available at lower prices through the TrumpRx.gov website, which will launch in January.[1] Other companies such as Merck, Bristol Myers Squibb and Pfizer agreed to lower prices in exchange for exemption from duties for three years.[2][3]